EUVIMEDEUVIMED entdecken
Open Access

The Safety of Adiponectin Receptor Agonist AdipoRon in a Rabbit Model of Arthrofibrosis

Harold I Salmons, Christopher Gow, Afton K Limberg, Jacob W Bettencourt, Mason F Carstens, Ashley N Payne, Mark E Morrey, Joaquin Sanchez-Sotelo, Daniel J Berry, Amel Dudakovic, Matthew P Abdel

Tissue Engineering Part C: Methods · 2023

DOI: 10.1089/ten.tec.2023.0008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tissue Engineering Part C: Methods, 2023. Verfasst von Harold I Salmons und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery and Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Receptors, Adiponectin, Adiponectin. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AdipoRon is an adiponectin receptor 1, 2 (ADIPOR1 and ADIPOR2) agonist with numerous reported physiological benefits in murine models of human disease, including a proposed reduction in fibrosis. However, AdipoRon has never been investigated in rabbits, which provide a robust model for orthopedic conditions. We examined the safety of intravenous (IV) AdipoRon in New Zealand White (NZW) female rabbits surgically stressed by a procedure that mimics human arthrofibrosis. Fifteen female NZW rabbits were prospectively studied using increasing AdipoRon doses based on established literature. AdipoRon was dissolved in dimethyl sulfoxide (DMSO), diluted in normal saline, and administered IV preoperatively and for 5 subsequent days postoperatively. The primary outcome was overall toxicity to rabbits, whereas secondary outcomes were change in rabbit weights and hemodynamics and defining acid-base characteristics of the drug formulation. Two rabbits expired during preoperative drug administration at 25 mg/kg. Remaining rabbits received preoperative doses of DMSO (vehicle), 2.5, 5, or 10 mg/kg of AdipoRon without complications. On postoperative day 1, one rabbit sustained a tonic-clonic seizure after their second dose of 10 mg/kg AdipoRon. The remaining 12 rabbits (4 in each group) received six serial doses of vehicle, 2.5, or 5 mg/kg of AdipoRon without adverse effects. All formulations of AdipoRon were within safe physiological pH ranges (4-5). We are the first to report the use of IV AdipoRon in a surgically stressed rabbit model of orthopedic disease. AdipoRon doses of 5 mg/kg or less appear to be well-tolerated in female NZW rabbits. Impact statement We provided the first in vivo toxicity assessment and dose optimization of a new antifibrotic experimental medication, AdipoRon, in a surgically stressed rabbit model of knee arthrofibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AdiponectinAdiponectinMiceHumansRabbitsFemaleAnimalsDimethyl SulfoxidePiperidines

Stichwörter der Autor:innen

adiponectinarthrofibrosisintravenouskneetoxicity

Substanzen

AdipoRonReceptors, AdiponectinAdiponectinDimethyl SulfoxidePiperidines

Autor:innen und Institutionen

  • Department of Orthopedic Surgery and Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Comparative Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Förderung

  • NIAMS NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Salmons, H. I., Gow, C., Limberg, A. K., Bettencourt, J. W., Carstens, M. F., Payne, A. N., Morrey, M. E., Sanchez-Sotelo, J., Berry, D. J., Dudakovic, A., & Abdel, M. P. (2023). The Safety of Adiponectin Receptor Agonist AdipoRon in a Rabbit Model of Arthrofibrosis. Tissue Engineering Part C: Methods. https://doi.org/10.1089/ten.tec.2023.0008

Vancouver

Salmons HI, Gow C, Limberg AK, Bettencourt JW, Carstens MF, Payne AN, et al. The Safety of Adiponectin Receptor Agonist AdipoRon in a Rabbit Model of Arthrofibrosis. Tissue Engineering Part C: Methods. 2023. doi:10.1089/ten.tec.2023.0008

BibTeX
@article{Salmons2023,
  author = {Salmons, Harold I and Gow, Christopher and Limberg, Afton K and Bettencourt, Jacob W and Carstens, Mason F and Payne, Ashley N and Morrey, Mark E and Sanchez-Sotelo, Joaquin and Berry, Daniel J and Dudakovic, Amel and Abdel, Matthew P},
  title = {The Safety of Adiponectin Receptor Agonist AdipoRon in a Rabbit Model of Arthrofibrosis},
  journal = {Tissue Engineering Part C: Methods},
  year = {2023},
  doi = {10.1089/ten.tec.2023.0008}
}
Kostenlos starten →